Scarica l'app Stockscreener
30.44
5.84%
1.68
Dopo l'orario di chiusura:
29.85
-0.59
-1.94%
Precedente Chiudi:
$28.76
Aprire:
$28.745
Volume 24 ore:
17,863
Relative Volume:
0.35
Capitalizzazione di mercato:
$285.45M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+0.55%
1M Prestazione:
+15.57%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$28.75
$30.65
Intervallo di 1 settimana:
$28.20
$30.69
Portata 52W:
$15.80
$34.31
Tvardi Therapeutics Inc Stock (TVRD) Company Profile
Nome
Tvardi Therapeutics Inc
Settore
Industria
Telefono
(713) 489-8654
Indirizzo
3 SUGAR CREEK CTR. BLVD., SUGAR LAND
Confronta TVRD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TVRD
Tvardi Therapeutics Inc
|
30.44 | 277.38M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Tvardi Therapeutics Inc Stock (TVRD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-14 | Iniziato | Raymond James | Outperform |
| 2025-07-11 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-06-12 | Iniziato | Piper Sandler | Overweight |
| 2025-05-21 | Iniziato | Oppenheimer | Outperform |
| 2025-05-15 | Iniziato | BTIG Research | Buy |
| 2024-06-13 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2024-06-13 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2024-06-13 | Downgrade | Needham | Buy → Hold |
| 2024-06-13 | Downgrade | Stifel | Buy → Hold |
| 2023-03-08 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-03-08 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-11-01 | Ripresa | Canaccord Genuity | Buy |
| 2021-08-03 | Iniziato | JP Morgan | Neutral |
| 2020-04-21 | Reiterato | H.C. Wainwright | Buy |
| 2019-08-12 | Reiterato | H.C. Wainwright | Buy |
| 2019-05-29 | Reiterato | Laidlaw | Buy |
| 2019-02-06 | Ripresa | Jefferies | Buy |
| 2019-01-15 | Iniziato | BofA/Merrill | Neutral |
| 2018-09-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-09-13 | Iniziato | Jefferies | Buy |
| 2018-08-08 | Reiterato | Stifel | Buy |
| 2018-06-28 | Reiterato | H.C. Wainwright | Buy |
| 2018-03-12 | Ripresa | H.C. Wainwright | Buy |
| 2018-02-12 | Aggiornamento | Janney | Neutral → Buy |
| 2018-01-19 | Iniziato | Seaport Global Securities | Buy |
Mostra tutto
Tvardi Therapeutics Inc Borsa (TVRD) Ultime notizie
What’s Tvardi Therapeutics Inc.’s historical returnShare Buyback & Consistent Return Investment Signals - khodrobank.com
Will breakout in Tvardi Therapeutics Inc. lead to full recoveryJuly 2025 Big Picture & High Return Stock Watch Alerts - Newser
Published on: 2025-09-03 09:20:00 - Newser
Is now a turning point for Tvardi Therapeutics Inc.Weekly Risk Report & Verified Entry Point Signals - Newser
Is Tvardi Therapeutics Inc. stock poised for growthMarket Performance Summary & Weekly High Potential Alerts - Newser
How to read the order book for Tvardi Therapeutics Inc.Buy Signal & Accurate Entry/Exit Alerts - Newser
What momentum shifts mean for Tvardi Therapeutics Inc.2025 Risk Factors & Expert Approved Trade Ideas - Newser
Can trapped investors hope for a rebound in Tvardi Therapeutics Inc.2025 EndofYear Setup & Free Fast Gain Swing Trade Alerts - Newser
Market Overview: Can Tvardi Therapeutics Inc. deliver consistent EPS growthPortfolio Return Summary & High Conviction Buy Zone Alerts - khodrobank.com
Is it too late to sell Tvardi Therapeutics Inc.Earnings Trend Report & Daily Profit Maximizing Tips - Newser
What’s the RSI of Tvardi Therapeutics Inc. stockQuarterly Earnings Summary & Consistent Profit Trading Strategies - khodrobank.com
Does Tvardi Therapeutics Inc. qualify in momentum factor screeningTrade Analysis Report & Daily Risk Controlled Trade Plans - Newser
Short interest data insights for Tvardi Therapeutics Inc.Take Profit & Long-Term Capital Growth Strategies - Newser
What recovery options are there for Tvardi Therapeutics Inc.July 2025 PreEarnings & AI Enhanced Trading Alerts - Newser
Identifying reversal signals in Tvardi Therapeutics Inc.Market Movement Recap & High Accuracy Buy Signal Tips - Newser
Real time social sentiment graph for Tvardi Therapeutics Inc.Quarterly Portfolio Summary & Stepwise Trade Signal Implementation - Newser
What are the analyst revisions for Tvardi Therapeutics Inc.Is QNST stock a good investment in YEAR2025 Dividend Review & AI Based Trade Execution Alerts - khodrobank.com
Tvardi Therapeutics Inc. Included in Top Momentum Scan getLinesFromResByArray error: size == 0 - thegnnews.com
Why Tvardi Therapeutics Inc. is moving todayJuly 2025 Macro Moves & Low Risk High Win Rate Stock Picks - Newser
Can Tvardi Therapeutics Inc. deliver consistent EPS growthMarket Performance Summary & Free Long-Term Investment Growth Plans - khodrobank.com
How to use Fibonacci retracement on Tvardi Therapeutics Inc.Weekly Gains Summary & Risk Adjusted Buy/Sell Alerts - Newser
Applying Elliott Wave Theory to Tvardi Therapeutics Inc.Inflation Watch & Free Expert Verified Stock Movement Alerts - Newser
Tvardi Therapeutics Inc. stock chart pattern explainedQuarterly Trade Review & High Conviction Buy Zone Alerts - Newser
Can Tvardi Therapeutics Inc. recover in the next quarter2025 EndofYear Setup & Accurate Entry and Exit Point Alerts - Newser
Is Tvardi Therapeutics Inc. reversing from oversold territory2025 Key Lessons & Expert Approved Momentum Trade Ideas - Newser
Tvardi Therapeutics (NASDAQ:TVRD) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Tvardi Therapeutics Faces Legal and Financial Risks from Exclusive Forum Provision - MSN
Volatility clustering patterns for Tvardi Therapeutics Inc.2025 AllTime Highs & Safe Capital Growth Trade Ideas - Newser
How to manage a losing position in Tvardi Therapeutics Inc.July 2025 Technicals & Low Risk Entry Point Guides - Newser
Visual trend scoring systems applied to Tvardi Therapeutics Inc.2025 Support & Resistance & Long-Term Growth Stock Strategies - Newser
Top chart patterns to watch in Tvardi Therapeutics Inc.July 2025 Sentiment & Stepwise Trade Execution Plans - Newser
Tvardi Therapeutics Inc Azioni (TVRD) Dati Finanziari
Non sono disponibili dati finanziari per Tvardi Therapeutics Inc (TVRD). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
Tvardi Therapeutics Inc Azioni (TVRD) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Terrillion Scott | SEC'Y; CHIEF COMPLIANCE & G.C. |
Feb 28 '25 |
Sale |
4.76 |
163 |
776 |
7,190 |
| Posner Christopher | PRESIDENT AND CEO |
Feb 04 '25 |
Sale |
4.72 |
372 |
1,756 |
13,692 |
| Posner Christopher | PRESIDENT AND CEO |
Nov 04 '24 |
Sale |
0.29 |
3,668 |
1,064 |
168,768 |
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):